Cervical cancer remains a leading cause of death for women in Mexico

Cervical cancer remains the second leading cause of cancer death among women in Mexico, particularly affecting those aged 25 to 34. Medical experts emphasize that the disease is preventable and treatable through early detection and vaccination.

Prevention strategies include strengthening national Human Papillomavirus (HPV) vaccination campaigns, aligned with the World Health Organization's 90-70-90 strategy. This global goal aims to vaccinate 90% of girls before age 15, ensure 70% of women have access to screening, and guarantee that 90% of those with precancerous lesions or cancer receive timely treatment.

Risk factors identified include early onset of sexual activity, having multiple sexual partners, and contact with high-risk individuals. Pro Oncavi highlights the importance of HPV vaccines for children starting at age 9 and women from age 25, alongside regular Pap smears and HPV testing. Challenges to prevention include social stigma, gender inequality in healthcare access, and limited medical infrastructure in rural or marginalized areas.